ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Kiniksa Pharmaceuticals International, Plc

Kiniksa Pharmaceuticals International, Plc is an active company incorporated on 9 April 2024 with the registered office located in London, Greater London. Kiniksa Pharmaceuticals International, Plc was registered 1 year 5 months ago.
Status
Active
Active since incorporation
Company No
15630565
Public limited company
Age
1 year 5 months
Incorporated 9 April 2024
Size
Large
Turnover is over £54M
Balance sheet is over £27M
Confirmation
Submitted
Dated 8 April 2025 (5 months ago)
Next confirmation dated 8 April 2026
Due by 22 April 2026 (7 months remaining)
Last change occurred 4 months ago
Accounts
Submitted
For period 9 Apr31 Dec 2024 (8 months)
Accounts type is Full
Next accounts for period 31 December 2025
Due by 30 June 2026 (9 months remaining)
Contact
Address
Third Floor
23 Old Bond Street
London
W1S 4PZ
United Kingdom
Same address since incorporation
Telephone
Unreported
Email
Unreported
People
Officers
14
Shareholders
4
Controllers (PSC)
2
Director • PSC • British,American • Lives in United States • Born in Jul 1969
Director • American • Lives in United States • Born in Dec 1958
Director • American • Lives in United States • Born in Sep 1970
Director • Investment Professional • American • Lives in United States • Born in Dec 1979
Director • British • Lives in UK • Born in Oct 1980
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Kiniksa Pharmaceuticals (UK), Ltd
Ross Michael Moat is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2023–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£146.62M
Increased by £61.88M (+73%)
Turnover
£338.02M
Increased by £125.89M (+59%)
Employees
Unreported
Same as previous period
Total Assets
£463.66M
Increased by £50.54M (+12%)
Total Liabilities
-£113.5M
Increased by £44.84M (+65%)
Net Assets
£350.16M
Increased by £5.7M (+2%)
Debt Ratio (%)
24%
Increased by 7.86% (+47%)
Latest Activity
Shares Cancelled
1 Month Ago on 22 Jul 2025
Shares Cancelled
1 Month Ago on 18 Jul 2025
Baker Bros. Advisors Lp (PSC) Resigned
2 Months Ago on 1 Jul 2025
Full Accounts Submitted
2 Months Ago on 11 Jun 2025
Confirmation Submitted
4 Months Ago on 15 Apr 2025
Ms Cantey Boyd Appointed
11 Months Ago on 4 Oct 2024
Sanjiv Patel (PSC) Appointed
1 Year 2 Months Ago on 28 Jun 2024
Baker Bros. Advisors Lp (PSC) Appointed
1 Year 2 Months Ago on 28 Jun 2024
Kiniksa Pharmaceuticals, Ltd. (PSC) Resigned
1 Year 2 Months Ago on 28 Jun 2024
Felix Baker (PSC) Appointed
1 Year 2 Months Ago on 27 Jun 2024
Get Credit Report
Discover Kiniksa Pharmaceuticals International, Plc's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Statement of capital on 26 June 2025
Submitted on 18 Aug 2025
Statement of capital following an allotment of shares on 8 July 2025
Submitted on 13 Aug 2025
Court order
Submitted on 31 Jul 2025
Statement of capital on 31 July 2025
Submitted on 31 Jul 2025
Miscellaneous
Submitted on 31 Jul 2025
Statement of capital following an allotment of shares on 8 July 2025
Submitted on 22 Jul 2025
Cancellation of shares. Statement of capital on 30 June 2025
Submitted on 22 Jul 2025
Cancellation of shares. Statement of capital on 30 June 2025
Submitted on 18 Jul 2025
Statement of capital following an allotment of shares on 30 June 2025
Submitted on 14 Jul 2025
Statement of capital following an allotment of shares on 29 May 2025
Submitted on 9 Jul 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year